Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Dodge

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621Jonathan E Kolitz, Stephen L George, Richard K Dodge, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 1996
Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomasD E Thrall, D M Prescott, T V Samulski, et al.
Cancer|March 11, 2003
Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311Ted P Szatrowski, Richard K Dodge, Carol Reynolds, et al.
Blood|May 26, 1999
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experienceM Wetzler, R K Dodge, K Mrózek, et al.
Blood|May 23, 2001
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)M R Baer, C C Stewart, R K Dodge, et al.
Blood|February 21, 2004
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemiaMikkael A Sekeres, Bercedis Peterson, Richard K Dodge, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2001
Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading methodS K Kang, R H Chou, R K Dodge, et al.
Blood|October 24, 2002
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)John C Byrd, Krzysztof Mrózek, Richard K Dodge, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621Jonathan E Kolitz, Stephen L George, Richard K Dodge, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 1996
Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomasD E Thrall, D M Prescott, T V Samulski, et al.
Cancer|March 11, 2003
Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311Ted P Szatrowski, Richard K Dodge, Carol Reynolds, et al.
Blood|May 26, 1999
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experienceM Wetzler, R K Dodge, K Mrózek, et al.
Blood|May 23, 2001
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)M R Baer, C C Stewart, R K Dodge, et al.
Blood|February 21, 2004
Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemiaMikkael A Sekeres, Bercedis Peterson, Richard K Dodge, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2001
Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading methodS K Kang, R H Chou, R K Dodge, et al.
Blood|October 24, 2002
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)John C Byrd, Krzysztof Mrózek, Richard K Dodge, et al.
Pageof 13